EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multicenter, open-label, safety and efficacy study of zonisamide in patients with progressive myoclonic epilepsy



Multicenter, open-label, safety and efficacy study of zonisamide in patients with progressive myoclonic epilepsy



Neurology 58(7 Supplement 3): A296-A297, April 9




(PDF emailed within 1 workday: $29.90)

Accession: 035349977

Download citation: RISBibTeXText



Related references

Zonisamide for the treatment of myoclonic seizures in progressive myoclonic epilepsy: an open-label study. Epileptic Disorders 10(1): 31-34, 2008

Multicenter, open-label assessment of the efficacy and safety of zonisamide as adjunctive therapy for primary generalized epilepsy. Epilepsia 43(Supplement 7): 190, 2002

Short-term efficacy and safety of zonisamide as adjunctive treatment for refractory partial seizures: a multicenter open-label single-arm trial in Korean patients. Seizure 21(3): 188-193, 2012

Safety of 25- and 50-mg capsules in the initiation of zonisamide therapy in patients with epilepsy: an uncontrolled, open-label study. Current Medical Research and Opinion 20(6): 837-842, 2004

Effectiveness of open-label zonisamide in juvenile myoclonic epilepsy. Epilepsia 42(Supplement 7): 184, 2001

Two open-label, multicenter studies of the safety and efficacy of gabapentin in patients with refractory epilepsy. Epilepsia 33(SUPPL 3): 77, 1992

Zonisamide in children and young adults with refractory epilepsy: an open label, multicenter Italian study. Epilepsy Research 83(2-3): 112-116, 2009

Long-term safety of zonisamide in children with epilepsy: A multicentre, open-label extension study. 2007

Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy. European Journal of Paediatric Neurology 13(1): 3-9, 2008

Short-term efficacy and safety of valproate sustained-release formulation in newly diagnosed partial epilepsy VIPe-study. A multicenter observational open-label study. Saudi Medical Journal 28(9): 1402-1407, 2007

Efficacy, safety and effect on the quality of life of gabapentin in adult epilepsy--results of a prospective open-label quasi naturalistic Hungarian multicenter study (phase human-IV). Ideggyogyaszati Szemle 59(9-10): 361-372, 2006

Safety and efficacy of zonisamide as adjunctive therapy for refractory complex partial seizures An open label study. Epilepsia 41(Supplement 7): 225-226, 2000

Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis. International Journal of Hematology (): -, 2016

A multicenter, open-label study of the efficacy and safety of telmisartan in mild to moderate hypertensive patients. Arquivos Brasileiros de Cardiologia 79(4): 339-350, 2002

An open-label, multicenter study of the efficacy and safety of peginterferon alfa-2a , alone, or in combination with ribavirin , in patients with HIV/HCV co-infection. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 43: 310, 2003